Tau Mutations as a Novel Risk Factor for Cancer-Letter
Cancer Res
.
2018 Nov 15;78(22):6523-6524.
doi: 10.1158/0008-5472.CAN-18-2313.
Epub 2018 Oct 29.
Authors
Angela B Deutschländer
1
,
Bradley F Boeve
2
,
Howard J Rosen
3
,
Adam L Boxer
3
,
Zbigniew K Wszolek
;
LEFFTDS Consortium
Affiliations
1
Department of Neurology, Mayo Clinic, Jacksonville, Florida. Deutschlander.angela@mayo.edu.
2
Department of Neurology, Mayo Clinic, Rochester, Minnesota.
3
Department of Neurology, University of California San Francisco, San Francisco, California.
PMID:
30373809
PMCID:
PMC6245649
DOI:
10.1158/0008-5472.CAN-18-2313
No abstract available
Publication types
Letter
Research Support, N.I.H., Extramural
Comment
MeSH terms
Humans
Mutation
Neoplasms*
Risk Factors
Grants and funding
K24 AG045333/AG/NIA NIH HHS/United States
U24 AG021886/AG/NIA NIH HHS/United States
U01 AG016976/AG/NIA NIH HHS/United States
P50 NS072187/NS/NINDS NIH HHS/United States
U01 AG045390/AG/NIA NIH HHS/United States
U54 NS092089/NS/NINDS NIH HHS/United States